These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30093524)

  • 1. Carboxamido steroids inhibit the opening properties of transient receptor potential ion channels by lipid raft modulation.
    Sághy É; Payrits M; Bíró-Sütő T; Skoda-Földes R; Szánti-Pintér E; Erostyák J; Makkai G; Sétáló G; Kollár L; Kőszegi T; Csepregi R; Szolcsányi J; Helyes Z; Szőke É
    J Lipid Res; 2018 Oct; 59(10):1851-1863. PubMed ID: 30093524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the role of lipid rafts and sphingomyelin in Ca2+-gating of Transient Receptor Potential channels in trigeminal sensory neurons and peripheral nerve terminals.
    Sághy É; Szőke É; Payrits M; Helyes Z; Börzsei R; Erostyák J; Jánosi TZ; Sétáló G; Szolcsányi J
    Pharmacol Res; 2015 Oct; 100():101-16. PubMed ID: 26238178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive Effects of Lipid Raft Disruptors, a Novel Carboxamido-Steroid and Methyl β-Cyclodextrin, in Mice by Inhibiting Transient Receptor Potential Vanilloid 1 and Ankyrin 1 Channel Activation.
    Horváth Á; Biró-Sütő T; Kántás B; Payrits M; Skoda-Földes R; Szánti-Pintér E; Helyes Z; Szőke É
    Front Physiol; 2020; 11():559109. PubMed ID: 33071817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolvin D1 and D2 Inhibit Transient Receptor Potential Vanilloid 1 and Ankyrin 1 Ion Channel Activation on Sensory Neurons via Lipid Raft Modification.
    Payrits M; Horváth Á; Biró-Sütő T; Erostyák J; Makkai G; Sághy É; Pohóczky K; Kecskés A; Kecskés M; Szolcsányi J; Helyes Z; Szőke É
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line.
    Szoke E; Börzsei R; Tóth DM; Lengl O; Helyes Z; Sándor Z; Szolcsányi J
    Eur J Pharmacol; 2010 Feb; 628(1-3):67-74. PubMed ID: 19958765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.
    Payrits M; Sághy É; Mátyus P; Czompa A; Ludmerczki R; Deme R; Sándor Z; Helyes Z; Szőke É
    Neuroscience; 2016 Jun; 324():151-62. PubMed ID: 26930003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADP-Induced Ca
    Certal M; Vinhas A; Barros-Barbosa A; Ferreirinha F; Costa MA; Correia-de-Sá P
    J Cell Physiol; 2017 Jun; 232(6):1511-1526. PubMed ID: 27755650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Nociceptive Effects of Sphingomyelinase and Methyl-Beta-Cyclodextrin in the Icilin-Induced Mouse Pain Model.
    Horváth Á; Steib A; Nehr-Majoros A; Kántás B; Király Á; Racskó M; Tóth BI; Szánti-Pintér E; Kudová E; Skoda-Földes R; Helyes Z; Szőke É
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic Effects of Lipid Raft Disruption by Sphingomyelinase and Myriocin via Transient Receptor Potential Vanilloid 1 and Transient Receptor Potential Ankyrin 1 Ion Channel Modulation.
    Horváth Á; Payrits M; Steib A; Kántás B; Biró-Süt T; Erostyák J; Makkai G; Sághy É; Helyes Z; Szőke É
    Front Pharmacol; 2020; 11():593319. PubMed ID: 33584270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lutein inhibits the function of the transient receptor potential A1 ion channel in different in vitro and in vivo models.
    Horváth G; Szoke É; Kemény Á; Bagoly T; Deli J; Szente L; Pál S; Sándor K; Szolcsányi J; Helyes Z
    J Mol Neurosci; 2012 Jan; 46(1):1-9. PubMed ID: 21541689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Raft Destabilization Impairs Mouse TRPA1 Responses to Cold and Bacterial Lipopolysaccharides.
    Startek JB; Talavera K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation.
    Banke TG; Chaplan SR; Wickenden AD
    Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1457-68. PubMed ID: 20457836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclodextrin derivatives decrease Transient Receptor Potential vanilloid 1 and Ankyrin 1 ion channel activation via altering the surrounding membrane microenvironment by cholesterol depletion.
    Nehr-Majoros AK; Erostyák J; Fenyvesi É; Szabó-Meleg E; Szőcs L; Sétáló G; Helyes Z; Szőke É
    Front Cell Dev Biol; 2024; 12():1334130. PubMed ID: 38481530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of molecular targets for toxic action by persulfate, an industrial sulfur compound.
    Shimada T; Takahashi K; Tominaga M; Ohta T
    Neurotoxicology; 2019 May; 72():29-37. PubMed ID: 30738091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etomidate and propylene glycol activate nociceptive TRP ion channels.
    Niedermirtl F; Eberhardt M; Namer B; Leffler A; Nau C; Reeh PW; Kistner K
    Mol Pain; 2018; 14():1744806918811699. PubMed ID: 30345869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lipid rafts on transient receptor potential channel activities.
    Bobkov D; Semenova S
    J Cell Physiol; 2022 Apr; 237(4):2034-2044. PubMed ID: 35014032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bimodal action of menthol on the transient receptor potential channel TRPA1.
    Karashima Y; Damann N; Prenen J; Talavera K; Segal A; Voets T; Nilius B
    J Neurosci; 2007 Sep; 27(37):9874-84. PubMed ID: 17855602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-induced sensitisation of the irritant receptor ion channel TRPA1.
    Meents JE; Fischer MJ; McNaughton PA
    J Physiol; 2016 Nov; 594(22):6643-6660. PubMed ID: 27307078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597).
    Niforatos W; Zhang XF; Lake MR; Walter KA; Neelands T; Holzman TF; Scott VE; Faltynek CR; Moreland RB; Chen J
    Mol Pharmacol; 2007 May; 71(5):1209-16. PubMed ID: 17314320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimycin A-induced mitochondrial dysfunction activates vagal sensory neurons via ROS-dependent activation of TRPA1 and ROS-independent activation of TRPV1.
    Stanford KR; Hadley SH; Barannikov I; Ajmo JM; Bahia PK; Taylor-Clark TE
    Brain Res; 2019 Jul; 1715():94-105. PubMed ID: 30914247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.